André P. Fay

6.4k total citations
117 papers, 2.5k citations indexed

About

André P. Fay is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, André P. Fay has authored 117 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pulmonary and Respiratory Medicine, 56 papers in Oncology and 36 papers in Cancer Research. Recurrent topics in André P. Fay's work include Renal cell carcinoma treatment (47 papers), Prostate Cancer Treatment and Research (36 papers) and Cancer Genomics and Diagnostics (26 papers). André P. Fay is often cited by papers focused on Renal cell carcinoma treatment (47 papers), Prostate Cancer Treatment and Research (36 papers) and Cancer Genomics and Diagnostics (26 papers). André P. Fay collaborates with scholars based in United States, Brazil and Spain. André P. Fay's co-authors include Toni K. Choueiri, Joaquim Bellmunt, Sabina Signoretti, Marcella Callea, Gordon J. Freeman, Jeffrey J. Leow, Laurence Albigès, F. Stephen Hodi, David F. McDermott and Michael B. Atkins and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

André P. Fay

110 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
André P. Fay United States	22	1.4k	1.3k	758	674	619	117	2.5k
Bradley A. McGregor United States	27	1.4k 1.0×	1.8k 1.4×	1.2k 1.6×	782 1.2×	573 0.9×	176	3.2k
Brigitte Laguerre France	25	1.8k 1.3×	972 0.8×	507 0.7×	919 1.4×	659 1.1×	152	2.6k
Marine Gross‐Goupil France	29	1.9k 1.3×	1.4k 1.1×	532 0.7×	995 1.5×	664 1.1×	175	2.9k
Thomas Powles United Kingdom	24	1.1k 0.8×	2.4k 1.9×	1.9k 2.6×	649 1.0×	430 0.7×	105	3.7k
Andrea Coinu Italy	21	772 0.6×	1.3k 1.0×	603 0.8×	394 0.6×	553 0.9×	36	2.2k
Jacqueline Vuky United States	25	681 0.5×	1.4k 1.1×	1.4k 1.9×	565 0.8×	279 0.5×	64	2.6k
Priya Rao United States	25	1.3k 0.9×	649 0.5×	508 0.7×	1.2k 1.7×	688 1.1×	95	2.2k
Thierry Gil Belgium	22	2.1k 1.5×	1.1k 0.9×	841 1.1×	668 1.0×	453 0.7×	94	3.5k
Atsunari Kawashima Japan	25	724 0.5×	744 0.6×	472 0.6×	734 1.1×	471 0.8×	116	1.9k
Bradley Curtis Carthon United States	20	706 0.5×	922 0.7×	455 0.6×	258 0.4×	225 0.4×	115	1.7k

Countries citing papers authored by André P. Fay

Since Specialization

Citations

This map shows the geographic impact of André P. Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André P. Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André P. Fay more than expected).

Fields of papers citing papers by André P. Fay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André P. Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André P. Fay. The network helps show where André P. Fay may publish in the future.

Co-authorship network of co-authors of André P. Fay

This figure shows the co-authorship network connecting the top 25 collaborators of André P. Fay. A scholar is included among the top collaborators of André P. Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André P. Fay. André P. Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maluf, Fernando Cotait, Karine Martins da Trindade, Daniel D’Almeida Preto, et al.. (2025). Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer. JAMA Oncology. 11(11). 1314–1314.

Agarwal, Neeraj, Arun Azad, Joan Carles, et al.. (2025). Final overall survival (OS) with talazoparib (TALA) + enzalutamide (ENZA) as first-line treatment in unselected patients with metastatic castration-resistant prostate cancer (mCRPC) in the phase 3 TALAPRO-2 trial.. Journal of Clinical Oncology. 43(5_suppl). 11 indexed citations

Werutsky, Gustavo, Juliana Giacomazzi, Daniela Dornelles Rosa, et al.. (2024). The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation. Revista Brasileira Ginecologia e Obstetrícia. 46.

Azad, Arun, André P. Fay, Cezary Szczylik, et al.. (2024). 1637P Efficacy of talazoparib and enzalutamide in mCRPC patients previously treated with androgen receptor pathway inhibitors (ARPI) or docetaxel: Post hoc analysis from both cohorts in TALAPRO-2 study. Annals of Oncology. 35. S987–S988. 1 indexed citations

Shore, Neal D., Michael S. Broder, Pedro C. Barata, et al.. (2024). Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy. European Urology Oncology. 8(1). 94–104. 1 indexed citations

Prá, Daniel, et al.. (2023). Discrimination of molecular subtypes of breast cancer with ATR-FTIR spectroscopy in blood plasma coupled with partial least square-artificial neural network discriminant analysis (PLS-ANNDA). Chemometrics and Intelligent Laboratory Systems. 237. 104826–104826. 7 indexed citations

Frasson, Antônio Luiz, Vinícius Duval da Silva, Guilherme Watte, et al.. (2023). Core Needle Biopsy Accuracy for Androgen Receptor Expression in Invasive Breast Cancer. Revista Brasileira Ginecologia e Obstetrícia. 45(9). e535–e541. 1 indexed citations

Monteiro, Fernando Sabino Marques, Ondřej Fiala, Francesco Massari, et al.. (2023). Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study. Clinical Genitourinary Cancer. 22(2). 305–314.e3. 4 indexed citations

Matsubara, Nobuaki, Karim Fizazi, Arun Azad, et al.. (2023). 1807P Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Subgroup analyses of the all-comers cohort from TALAPRO-2 by homologous recombination repair (HRR) status. Annals of Oncology. 34. S977–S978. 3 indexed citations

10.

Zéqui, Stênio de Cássio, Walter Henriques da Costa, André P. Fay, et al.. (2023). Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis. Pathology - Research and Practice. 253. 154918–154918. 3 indexed citations

11.

Powles, Thomas, Michiel S. van der Heijden, D. Castellano Gauna, et al.. (2020). 697O A phase III, randomized, open-label study of first-line durvalumab (D) with or without tremelimumab (T) vs standard of care chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE). Annals of Oncology. 31. S550–S551. 16 indexed citations

12.

Nassar, Amin H., Lana Hamieh, Kathryn P. Gray, et al.. (2019). Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular Cancer Therapeutics. 19(2). 690–696. 10 indexed citations

13.

Fay, André P., et al.. (2018). Rastreamento do câncer de próstata e o papel das campanhas de conscientização. 515–524. 2 indexed citations

14.

Velasco, Guillermo de, Aedín C. Culhane, André P. Fay, et al.. (2017). Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model. The Oncologist. 22(3). 286–292. 49 indexed citations

15.

Callea, Marcella, Laurence Albigès, Mamta Gupta, et al.. (2015). Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma. Cancer Immunology Research. 3(10). 1158–1164. 266 indexed citations

16.

Bellmunt, Joaquim, Stephanie A. Mullane, Lillian Werner, et al.. (2015). Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma. Annals of Oncology. 26(4). 812–817. 229 indexed citations

17.

Choueiri, Toni K., David J. Figueroa, André P. Fay, et al.. (2014). Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial. Clinical Cancer Research. 21(5). 1071–1077. 187 indexed citations

18.

Choueiri, Toni K., André P. Fay, Kathryn P. Gray, et al.. (2014). PD-L1 expression in nonclear-cell renal cell carcinoma. Annals of Oncology. 25(11). 2178–2184. 242 indexed citations

19.

Bellmunt, Joaquim, Francesc Pons, André P. Fay, et al.. (2014). Sequential Targeted Therapy After Pazopanib Therapy in Patients With Metastatic Renal Cell Cancer: Efficacy and Toxicity. Clinical Genitourinary Cancer. 12(4). 262–269. 10 indexed citations

20.

Choueiri, Toni K., André P. Fay, Robert Gagnon, et al.. (2013). The Role of Aberrant VHL/HIF Pathway Elements in Predicting Clinical Outcome to Pazopanib Therapy in Patients with Metastatic Clear-Cell Renal Cell Carcinoma. Clinical Cancer Research. 19(18). 5218–5226. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact